임신중독증 저용량아스피린 - 의학 (Medicine)

문서의 이전 판을 선택했습니다! 저장하면 이 자료로 새 판을 만듭니다.

{{tag>low dose aspirin preeclampsia}}
{{page>:틀#의학}}
====== 임신중독증 저용량아스피린 ======

Low-dose aspirin ranges from 60-150 mg daily but, in the United States, the usual dose is a 81-mg tablet

=====시기=====
 
 You should start taking low-dose aspirin between weeks 12 and 16 of your pregnancy.

=====효과=====
 
 A review of 45 randomized trials that included over 20,000 pregnant women taking daily low-dose aspirin showed significant evidence of the prevention of preeclampsia, severe preeclampsia, and fetal growth restriction when initiated before 16 weeks’ gestation. Low-dose aspirin initiated after 16 weeks’ gestation may not be as effective at reducing the risk of preeclampsia, severe preeclampsia, and fetal growth restriction. Women at high risk for those outcomes should be identified in early pregnancy.[v]
 
 
=====안전성=====
 No increase in infant loss, growth problems, or cognition harm to the baby;
No statistically significant impact on risk of placental abruptions, postpartum hemorrhage (bleeding), or miscarriage to the mother;
No differences in developmental outcomes of the infants up to age 18 months.

=====중단시기=====
When should I stop taking low-dose aspirin?
It is very important that you ask your doctor when you should stop taking aspirin, as recommendations may be differ depending on your medical history.

There are opposing arguments regarding when to discontinue aspirin treatment. Some argue that aspirin should be discontinued at 36 weeks because of the possible bleeding risks associated with delivery.

Others argue, because most preeclampsia occurs after 36 weeks, that the aspirin may be beneficial to continue through delivery, into the postpartum period.

More research is needed, but again, it is imperative you discuss a stopping point with your healthcare professional if you are on a prenatal aspirin regimen.

=====효과=====

found a 2 to 5% risk reduction in the rate of preeclampsia.

https://www.preeclampsia.org/aspirin

2+1? 이 필드는 비어 있도록 유지하세요:

편집 요약

참고: 이 문서를 편집하면 내용은 다음 라이선스에 따라 배포하는 데 동의하는 것으로 간주합니다: CC Attribution-Noncommercial-Share Alike 4.0 International

연결문서